DLA Piper
Professional Services |
Law Firms
Houston, TX 77002
Recent News About DLA Piper
View More
-
DLA Piper advised Alimera Sciences, Inc., a global pharmaceutical company focused on ophthalmic solutions, in its acquisition by ANI Pharmaceuticals, a diversified biopharmaceutical company, in a transaction that values Alimera at approximately US$381 million in up front consideration plus contingent value rights providing for additional consideration upon the achievement of certain revenue milestones.
